(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.67% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Avient's revenue in 2025 is $3,240,400,000.On average, 5 Wall Street analysts forecast AVNT's revenue for 2025 to be $299,081,540,432, with the lowest AVNT revenue forecast at $291,115,436,309, and the highest AVNT revenue forecast at $303,496,597,669. On average, 5 Wall Street analysts forecast AVNT's revenue for 2026 to be $311,763,902,988, with the lowest AVNT revenue forecast at $302,801,384,345, and the highest AVNT revenue forecast at $318,300,993,058.
In 2027, AVNT is forecast to generate $326,439,094,585 in revenue, with the lowest revenue forecast at $318,300,352,983 and the highest revenue forecast at $333,833,885,693.